What is InBrace?
InBrace, based in Irvine, California, has developed a novel orthodontic treatment system that utilizes a smart wire technology. This innovative approach aims to revolutionize the way orthodontic corrections are performed, offering a potentially more efficient and effective solution for patients seeking alignment of their teeth. The company's technology represents a significant advancement in the field of orthodontics, positioning it as a key player in the dental technology market.
How much funding has InBrace raised?
InBrace has raised a total of $218.6M across 6 funding rounds:
Series A
$5.6M
Series B
$20M
Series C
$45M
Debt
$1M
Series D
$102M
Debt
$45M
Series A (2017): $5.6M, investors not publicly disclosed
Series B (2018): $20M, investors not publicly disclosed
Series C (2019): $45M supported by Novo Holdings, Vivo Capital, and venBio Partners
Debt (2020): $1M featuring PPP
Series D (2021): $102M backed by Farallon Capital Management, Endeavour Vision, MVM Partners, Soleus Capital, BlackRock, RTW Investments, and Marshall Wace
Debt (2022): $45M with participation from Horizon Technology Finance
Key Investors in InBrace
Farallon Capital Management
Farallon Capital Management is an investment firm with a broad investment mandate, likely participating in various sectors including healthcare and technology, providing significant capital for growth-stage companies.
Endeavour Vision
Endeavour Vision is a venture capital firm specializing in transformative healthcare technologies, particularly in medical devices and digital health, indicating a focus on innovative medical solutions.
MVM Partners
MVM Partners LLP invests in innovative healthcare companies, actively supporting businesses that enhance healthcare delivery through quality and cost-effective solutions, suggesting a strategic interest in medical technology advancements.
What's next for InBrace?
With the recent influx of major strategic investment, InBrace is poised for accelerated growth and market expansion. The company is expected to leverage this capital to further enhance its product development, scale its operations, and broaden its market reach. This funding will likely support advancements in its smart wire technology, clinical validation, and commercialization efforts, solidifying its position in the competitive orthodontic landscape and driving innovation in patient care.
See full InBrace company page
